Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
180.00
+1.90 (1.07%)
Jun 30, 2026, 4:08 PM HKT

HKG:2637 Statistics

Total Valuation

HKG:2637 has a market cap or net worth of HKD 14.17 billion. The enterprise value is 12.81 billion.

Market Cap14.17B
Enterprise Value 12.81B

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date Mar 30, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2637 has 78.71 million shares outstanding.

Current Share Class 78.71M
Shares Outstanding 78.71M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 28.80%
Owned by Institutions (%) 6.04%
Float 14.27M

Valuation Ratios

The trailing PE ratio is 63.51 and the forward PE ratio is 61.63.

PE Ratio 63.51
Forward PE 61.63
PS Ratio 21.86
PB Ratio 7.99
P/TBV Ratio 7.99
P/FCF Ratio 110.62
P/OCF Ratio 79.63
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 57.56, with an EV/FCF ratio of 100.01.

EV / Earnings 65.02
EV / Sales 19.77
EV / EBITDA 57.56
EV / EBIT 59.87
EV / FCF 100.01

Financial Position

The company has a current ratio of 6.31, with a Debt / Equity ratio of 0.07.

Current Ratio 6.31
Quick Ratio 6.06
Debt / Equity 0.07
Debt / EBITDA 0.55
Debt / FCF 0.96
Interest Coverage 33.52

Financial Efficiency

Return on equity (ROE) is 16.58% and return on invested capital (ROIC) is 49.21%.

Return on Equity (ROE) 16.58%
Return on Assets (ROA) 9.23%
Return on Invested Capital (ROIC) 49.21%
Return on Capital Employed (ROCE) 11.88%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 3.24M
Profits Per Employee 984,998
Employee Count200
Asset Turnover 0.45
Inventory Turnover 2.12

Taxes

In the past 12 months, HKG:2637 has paid 23.42 million in taxes.

Income Tax 23.42M
Effective Tax Rate 10.63%

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 211.25
200-Day Moving Average n/a
Relative Strength Index (RSI) 45.85
Average Volume (20 Days) 143,018

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2637 had revenue of HKD 648.05 million and earned 197.00 million in profits. Earnings per share was 2.83.

Revenue648.05M
Gross Profit 540.33M
Operating Income 213.95M
Pretax Income 220.42M
Net Income 197.00M
EBITDA 220.22M
EBIT 213.95M
Earnings Per Share (EPS) 2.83
Full Income Statement

Balance Sheet

The company has 1.48 billion in cash and 122.57 million in debt, with a net cash position of 1.36 billion or 17.25 per share.

Cash & Cash Equivalents 1.48B
Total Debt 122.57M
Net Cash 1.36B
Net Cash Per Share 17.25
Equity (Book Value) 1.77B
Book Value Per Share 22.53
Working Capital 1.35B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 177.92 million and capital expenditures -49.84 million, giving a free cash flow of 128.07 million.

Operating Cash Flow 177.92M
Capital Expenditures -49.84M
Depreciation & Amortization 6.51M
Net Borrowing 79.55M
Free Cash Flow 128.07M
FCF Per Share 1.63
Full Cash Flow Statement

Margins

Gross margin is 83.38%, with operating and profit margins of 33.01% and 30.40%.

Gross Margin 83.38%
Operating Margin 33.01%
Pretax Margin 34.01%
Profit Margin 30.40%
EBITDA Margin 33.98%
EBIT Margin 33.01%
FCF Margin 19.76%

Dividends & Yields

HKG:2637 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 1.39%
FCF Yield 0.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Analyst Forecast

The average price target for HKG:2637 is 289.66, which is 60.92% higher than the current price. The consensus rating is "Strong Buy".

Price Target 289.66
Price Target Difference 60.92%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (3Y) 18.21%
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2637 has an Altman Z-Score of 23.3 and a Piotroski F-Score of 3.

Altman Z-Score 23.3
Piotroski F-Score 3